Tapering Off Antidepressants: What New 2026 Research Says About Withdrawal vs. Relapse
If your mood or anxiety worsens while tapering an antidepressant, you may immediately wonder, “Is my depression or anxiety coming back?” That fear can feel overwhelming, especially if you have worked hard to feel stable.
New mental health news from September 2026 offers an important reason to pause before assuming the worst. Research led by Adelaide University and Swiss researchers suggests that mood and anxiety changes during antidepressant tapering are often related to withdrawal, rather than a true relapse of the original condition.
This does not mean every symptom is withdrawal, and it does not mean medication should be stopped. It does mean you deserve a careful, individualized conversation with a knowledgeable prescriber before making conclusions about what your symptoms mean.
What the September 2026 research found
The study followed more than 30 people in Switzerland as they reduced their antidepressant doses over approximately six months. Researchers observed that many participants experienced increased anxiety and lower mood after dose reductions, but that these symptoms often settled when the dose remained steady.
The study was published in Psychotherapy and Psychosomatics, and Adelaide University’s research summary describes the findings in accessible language.
The central message is this: when emotional symptoms appear soon after a dose reduction and occur alongside physical withdrawal symptoms, withdrawal may be more likely than relapse.
The researchers also found that worsening mood was substantially connected with symptoms such as:
Headache
Dizziness
“Brain zaps” or electric-shock sensations
Increased anxiety
Irritability or agitation
Sleep disruption
Nausea or flu-like feelings
When researchers accounted for withdrawal-related effects, the apparent worsening in depression scores was no longer significant in the same way. This suggests that some symptoms previously interpreted as a return of depression may actually reflect the nervous system adjusting to a medication change.
That distinction matters because withdrawal and relapse may require different forms of support.

Withdrawal may follow a “wave pattern”
One of the most helpful ideas from this research is the wave pattern of withdrawal.
Withdrawal symptoms may increase after a dose reduction, then settle when the dose is held steady. Later, another reduction may trigger another wave. The experience can feel unpredictable: one day may be manageable, while the next brings dizziness, anxiety, low mood, or brain zaps.
Relapse often follows a different pattern. It may develop more gradually and become steadily more persistent over weeks or months. It may also resemble the original symptoms of depression or anxiety without the new physical sensations commonly associated with withdrawal.
These patterns are not a diagnostic test. Everyone’s experience is different, and medication type, dose, length of treatment, prior withdrawal experiences, physical health, and stress can all influence what happens.
Still, tracking the timing of symptoms can give you and your prescriber valuable information. Consider recording:
The date and amount of each dose reduction
When emotional or physical symptoms begin
Whether symptoms come in waves or steadily intensify
Sleep, appetite, energy, and concentration changes
Stressful events or major changes in your routine
Any thoughts of self-harm or feeling unsafe
A written record can help your care team respond thoughtfully instead of making a rushed assumption.
Why slower, hyperbolic tapering may help
The new findings reinforce the importance of tapering slowly rather than stopping suddenly. The researchers specifically pointed to a more careful, hyperbolic taper, such as the approach described in the Maudsley Deprescribing Guidelines.
In practical terms, hyperbolic tapering generally means reducing by a small fraction of the current dose rather than making the same fixed milligram reduction each time. As the dose becomes smaller, the reductions may also need to become smaller.
This approach recognizes that the final stages of tapering can be difficult for some people. A reduction that seems small on paper may still feel significant to the body and brain.
The appropriate pace is not the same for everyone. Some people may taper over months; others may need longer. A prescriber may recommend pausing, making smaller reductions, or adjusting the plan if symptoms become difficult.
I want to emphasize an important safety message: do not stop an antidepressant abruptly or change your dose without speaking with your prescriber. Do not use someone else’s tapering schedule as your own. Liquid formulations, compounded capsules, or other options may sometimes help with very small reductions, but these decisions must be made with a qualified medical professional.
Therapy and medication can work together
Tapering can bring up more than physical symptoms. You may feel frightened, discouraged, or unsure whether you can trust your own mind. You may worry that needing medication means you are failing, or that experiencing withdrawal means you will never be able to stop.
Therapy can provide a steady, respectful space to process those concerns. I can help you:
Notice patterns without immediately catastrophizing
Separate symptoms from self-judgment
Build coping strategies for anxiety, low mood, and uncertainty
Practice grounding skills when physical sensations feel alarming
Prepare questions for your prescriber
Explore sleep, stress, relationships, and daily routines
Strengthen your sense of agency throughout the process
Therapy does not replace medical guidance, and a therapist should not tell you when or how to change a prescription. Instead, therapy and medication management can work together. With your permission, your therapist and prescriber may coordinate so your emotional support and medical care reflect the same goals.
This is also where conversations about emerging mental health biomarkers can be useful, but with appropriate caution. Biomarkers and symptom-tracking tools may eventually help clinicians understand individual patterns more precisely. At present, there is no single biomarker that can definitively tell you whether a mood change during tapering is withdrawal or relapse. Careful timing, clinical assessment, physical symptoms, and your personal history still matter.

What to discuss with your prescriber
If you are considering tapering, or if symptoms have already appeared, open communication is one of the most protective steps you can take. You might ask:
Could these symptoms be withdrawal, relapse, or another health concern?
How quickly should my dose be reduced?
Would smaller, percentage-based reductions be appropriate?
How long should I remain at each dose before changing it?
What physical or emotional symptoms should I monitor?
When should I contact you between appointments?
What is our plan if symptoms become severe?
Could therapy or another form of psychological support help during tapering?
If you experience severe symptoms, feel unable to stay safe, or have thoughts of harming yourself, seek immediate help. In the United States, call or text 988 for the Suicide & Crisis Lifeline, call 911 for an emergency, or go to the nearest emergency department.
A gentler way forward
This research does not promise that tapering will be easy. It does offer a more compassionate framework: a temporary increase in anxiety or low mood after a dose reduction does not automatically mean that your original condition has returned or that you must remain on medication forever.
You deserve time, careful assessment, and support. You also deserve a treatment plan that respects your history, your goals, and your right to make informed decisions about your care.
If you are navigating antidepressant withdrawal, anxiety, depression, or uncertainty about your next step, I invite you to reach out. At Talk to Heal Counseling Center, I provide a safe, supportive, and respectful space where we can explore what you are experiencing and identify practical ways to move forward. We offer contemporary psychotherapy, online booking, free consultations, and accept a wide range of insurance plans, including UHC, Aetna, Cigna, and others.
Book a consultation or book an appointment online. You can also call 404-369-3838.
Care is provided only in the State of Georgia.


Comments